| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 385.92B | 420.51B | 416.61B | 432.23B | 246.11B |
| Gross Profit | 203.86B | 225.40B | 307.86B | 277.78B | 201.49B |
| EBITDA | 252.14B | 261.70B | 235.74B | 260.92B | 156.55B |
| Net Income | 118.92B | 137.94B | 123.84B | 141.70B | 70.32B |
Balance Sheet | |||||
| Total Assets | 1.10T | 1.06T | 1.01T | 929.03B | 786.57B |
| Cash, Cash Equivalents and Short-Term Investments | 240.80B | 199.97B | 194.87B | 209.60B | 162.17B |
| Total Debt | 69.83B | 91.89B | 120.18B | 134.40B | 135.14B |
| Total Liabilities | 293.50B | 306.85B | 337.72B | 330.65B | 304.59B |
| Stockholders Equity | 803.09B | 747.55B | 666.59B | 597.18B | 480.91B |
Cash Flow | |||||
| Free Cash Flow | 96.91B | 97.53B | 92.38B | 110.82B | 65.46B |
| Operating Cash Flow | 205.58B | 220.89B | 213.34B | 205.57B | 147.89B |
| Investing Cash Flow | -127.02B | -175.43B | -78.09B | -98.47B | -96.23B |
| Financing Cash Flow | -80.70B | -97.94B | -84.23B | -64.96B | -33.33B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.37T | 7.65 | 15.25% | 6.76% | -3.90% | -11.54% | |
75 Outperform | HK$2.45T | 8.75 | 10.04% | 6.32% | -4.65% | -4.58% | |
74 Outperform | HK$1.15T | 17.31 | 13.43% | 8.97% | -6.04% | -7.87% | |
67 Neutral | HK$239.02B | 4.20 | 11.37% | 4.59% | -21.82% | -20.14% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | HK$203.77B | 9.73 | 11.62% | 8.02% | 7.29% | -48.69% | |
50 Neutral | HK$709.36B | 16.07 | 4.09% | 5.52% | -9.59% | -34.12% |